Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -27.03 |
peg ratio | -0.27 |
price to book ratio | 17.35 |
price to sales ratio | 15.43 |
enterprise value multiple | -14.20 |
price fair value | 17.35 |
profitability ratios | |
---|---|
gross profit margin | 92.96% |
operating profit margin | -98.12% |
pretax profit margin | -56.49% |
net profit margin | -56.64% |
return on assets | -17.07% |
return on equity | -85.25% |
return on capital employed | -37.09% |
liquidity ratio | |
---|---|
current ratio | 3.71 |
quick ratio | 3.65 |
cash ratio | 0.22 |
efficiency ratio | |
---|---|
days of inventory outstanding | 211.23 |
operating cycle | 296.80 |
days of payables outstanding | 69.39 |
cash conversion cycle | 227.42 |
receivables turnover | 4.27 |
payables turnover | 5.26 |
inventory turnover | 1.73 |
debt and solvency ratios | |
---|---|
debt ratio | 0.55 |
debt equity ratio | 2.08 |
long term debt to capitalization | 0.63 |
total debt to capitalization | 0.67 |
interest coverage | -8.26 |
cash flow to debt ratio | -0.50 |
cash flow ratios | |
---|---|
free cash flow per share | -5.53 |
cash per share | 12.15 |
operating cash flow per share | -5.30 |
free cash flow operating cash flow ratio | 1.04 |
cash flow coverage ratios | -0.50 |
short term coverage ratios | -2.90 |
capital expenditure coverage ratio | -22.81 |
Frequently Asked Questions
Blueprint Medicines Corporation (BPMC) published its most recent earnings results on 01-08-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Blueprint Medicines Corporation (NASDAQ:BPMC)'s trailing twelve months ROE is -85.25%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Blueprint Medicines Corporation (BPMC) currently has a ROA of -17.07%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
BPMC reported a profit margin of -56.64% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.71 in the most recent quarter. The quick ratio stood at 3.65, with a Debt/Eq ratio of 2.08.